RxDoctor Payments Data

Helena Longfellow

Family · Mahomet, ILNPI 1275131203

Payments from drug & device makers

$2,535in general payments, 2019–2025

Across 122 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$467
  • Amgen$428
  • Lilly USA, LLC$348
  • AbbVie$344
  • Novo Nordisk$178
  • Novartis$120
  • plus $650 from 18 others

What the payments were for

  • Food & beverage$2,528100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,535 in reported general payments places this provider in the 85th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin74$60,884
OzempicSemaglutide53$48,390
TrulicityDulaglutide36$44,592
FarxigaDapagliflozin Propanediol55$42,222
MounjaroTirzepatide36$38,674
XareltoRivaroxaban32$32,282
EliquisApixaban23$26,193
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$15,190
Breo ElliptaFluticasone/Vilanterol22$10,023
Lantus SolostarInsulin Glargine,hum.Rec.Anlog60$5,620
Venlafaxine Hcl ErVenlafaxine Hcl15$2,257
Morphine Sulfate ErMorphine Sulfate34$1,887
Humalog Kwikpen U-100Insulin Lispro11$1,218
Glipizide16$944
Atorvastatin Calcium99$648

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$348$83,26772 claims
Boehringer IngelheimJardiance$30$60,88474 claims
Novo NordiskOzempic$178$48,39053 claims
AstraZenecaFarxiga$467$42,22255 claims
Johnson & JohnsonXarelto$16$32,28232 claims
PfizerEliquis$20$26,19323 claims
GSKTrelegy Ellipta, Breo Ellipta$13$25,21242 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,941 family providers in Illinois.

Other family in Mahomet

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →